Just like we have learnt to advise hypertensive or hyperlipidemic patients on a healthy lifestyle but start therapy immediately, we need to recognize that many obese patients have wrestled with this for a lifetime, have tried multiple lifestyle interventions already
The glucagon receptor activation increases fat oxidation, which specifically targets stored fat for energy
In contrast to the liver toxicity of acetaminophen, NSAIDs exhibit varying degrees of gastrointestinal, cardiovascular, and kidney toxicity
Ipamorelins lack of cortisol rise is key excess cortisol can hinder weight loss, so its selectivity helps keep your fat loss on track
But it's the closest available drug to the "less GLP-1, more glucagon" thesis
A similar study published last year in Diabetes, Obesity and Metabolism found that switching from a weekly GLP-1 dose to a dose every other week helped people maintain about 75 percent of their weight loss